Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Havix Group
AddedFeb 17, 2024
UpdatedJun 18, 2026
Havix Group

Havix Group

Havix Group: A Georgia-based pharmaceutical company specializing in contract development and manufacturing.

HQ
Hoschton, GA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Havix Group, founded in 2015 and headquartered in Hoschton, Georgia, is a pharmaceutical company specializing in contract development and manufacturing (CDMO). Operating in stealth mode, Havix Group focuses on the development and production of high-quality generic pharmaceuticals. The company's core mission is to advance drug development through proficient research and a commitment to quality, aiming to provide reliable and effective pharmaceutical solutions to the market.

Notable for its USFDA approval, Havix Group has established itself as one of the fastest-growing pharmaceutical companies in the Atlanta region. The company collaborates with various partners to enhance its capabilities in drug development and manufacturing. Despite its relatively recent inception, Havix Group's impact on the pharmaceutical industry is significant, contributing to the availability of high-quality generic medications and fostering innovation within the sector.

Havix Group - Similar Companies

Har-Kcy logo

Har-Kcy

New Haven Pharmaceuticals logo

New Haven Pharmaceuticals

Accuitis logo

Accuitis

accuitis.com

Experic logo

Experic

Phlow logo

Phlow

phlow-usa.com

Pctrx logo

Pctrx

Selkirk Pharma logo

Selkirk Pharma

selkirkpharma.com

Handa Pharmaceuticals logo

Handa Pharmaceuticals

handapharma.com

Aviv Pharma logo

Aviv Pharma

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Dawah Pharmaceuticals logo

Dawah Pharmaceuticals

dawahpharma.com

6S Pharma logo

6S Pharma

6spharma.com

Vertice Pharma logo

Vertice Pharma

A&G Pharmaceutical logo

A&G Pharmaceutical

Havix Group - Quick Facts

Who are Havix Group's competitors?

Companies similar to Havix Group include Har-Kcy, New Haven Pharmaceuticals, Accuitis and Experic.

When was Havix Group founded?

Havix Group was founded in 2015.

Where is Havix Group's headquarters located?

Havix Group's headquarters is located in Hoschton, GA, US.

When was Havix Group's last funding round?

Havix Group's most recent funding round was for $600k (USD) in October 2017.

How much has Havix Group raised to-date?

As of Oct 24, 2017, Havix Group has raised a total of $2.5M (USD).

How many employees does Havix Group have?

Havix Group has 36 employees as of Feb 5, 2024.

Havix Group - Classification

Geographic Exposure
  • United States
Model
  • Manufacturing
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations